1. Home
  2. NEPH vs HOWL Comparison

NEPH vs HOWL Comparison

Compare NEPH & HOWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nephros Inc.

NEPH

Nephros Inc.

HOLD

Current Price

$5.43

Market Cap

60.0M

Sector

Health Care

ML Signal

HOLD

Logo Werewolf Therapeutics Inc.

HOWL

Werewolf Therapeutics Inc.

HOLD

Current Price

$0.98

Market Cap

64.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEPH
HOWL
Founded
1997
2017
Country
United States
United States
Employees
31
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
60.0M
64.5M
IPO Year
2004
2021

Fundamental Metrics

Financial Performance
Metric
NEPH
HOWL
Price
$5.43
$0.98
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$6.00
$7.00
AVG Volume (30 Days)
77.9K
540.4K
Earning Date
11-06-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.14
N/A
Revenue
$17,930,000.00
N/A
Revenue This Year
$33.32
N/A
Revenue Next Year
$12.27
N/A
P/E Ratio
$40.69
N/A
Revenue Growth
32.36
N/A
52 Week Low
$1.39
$0.60
52 Week High
$6.42
$2.38

Technical Indicators

Market Signals
Indicator
NEPH
HOWL
Relative Strength Index (RSI) 50.82 43.08
Support Level $5.06 $0.82
Resistance Level $5.97 $1.03
Average True Range (ATR) 0.58 0.09
MACD 0.04 0.03
Stochastic Oscillator 38.54 75.65

Price Performance

Historical Comparison
NEPH
HOWL

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.

Share on Social Networks: